The global peptides therapeutics market is expected to grow from $48.4 billion in 2023 to over $92 billion by 2030 (Grand View Research, 2024)
Drug compounding defined by the FDA as the process of combining, mixing or altering ingredients of a drug to create a medication tailored to a patients needs was the primary way drugs were produced until large-scale pharmaceutical manufacturing emerged early in the 20th century
Hydroxocobalamin is a long-acting, highly bioavailable form of B12, making it a preferred choice for both clinical use and B12 deficiency correction
Its unrelated but often searched in relation to diagnostic trouble codes
For example, proton pump inhibitors (PPIs) and H2 receptor antagonists, commonly used to treat gastroesophageal reflux disease (GERD), can reduce the absorption of vitamin B12 and may necessitate adjustments in the dosing of methylcobalamin
Yes, in many cases, they are part of a layered approach